Offering clinical trials is paramount, explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.
Offering clinical trials is paramount, explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.
Transcript
In addition to offering patients the best available treatments, how important is it for oncology practices to offer clinical trials?
I think offering clinical trials is paramount. It’s kind of interesting because I’ve been in healthcare almost 30 years, but I think clinical research is crucial when it comes to medical oncology and I think practices that don’t offer clinical research as a part of their offering, quite frankly, I think isn’t first of mind for the physicians who are taking care of medical oncology patients. So, having the ability to offer clinical research trials for patients that aren’t progressing well with standard of care is just giving the patient the best fighting chance.
It’s been a huge differentiator for us, especially in Florida, because we compete with 3 academic medical centers who have clinical research. Being able to offer clinical research in the community setting is a phenomenal benefit to patients.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More